Protocol summary

Study aim
Comparisson of the Efficacy of Ringer's Lactate Serum as a Base Solution in Modified Del Nido Cardioplegia with Standard Del Nido Cardioplegia on Myocardial Damage Markers and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft
Design
Randomized, single-blinded controlled trial, with parallel groups (allocation ratio 1:1).
Settings and conduct
This study is performed on patients who are candidates for coronary artery bypass surgery in Imam Hossein hospital (Tehran, Iran) in 1401. Eligible patients are divided into two groups (A and B) using a table of random numbers. In groups A and B, Ringer's lactate and plasmalite A solution are used for cardioplegia, respectively. Then, the markers of myocardial damage and the clinical outcomes of patients after surgery and at the admission to the intensive care unit are evaluated. In this single-blinded study, the patients are unaware of the allocation of individuals to the groups.
Participants/Inclusion and exclusion criteria
Inclusion criteria are: Candidate patients for coronary artery bypass graft, Candidate patients for 3 to 4 vascular grafts, Age between 18 and 75 years, Written informed consent to participate in the study, An ejection fraction higher than 35% before surgery, and Lack of multi-organ failure before surgery. Exclusion criteria are: Re-operation and Proven infection or inflammation within the last month
Intervention groups
In this study, Ringer's lactate solution is used to cardioplegia in group A (modified Del Nino). Also, in group B, plasmalit A solution is used to cardioplegia (Del Nino standard). Cardioplegic solution is a solution that is used to protect the myocardium during surgery and during the period when the heart is deprived of blood circulation.
Main outcome variables
Clinical outcomes; Myocardial damage markers

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20210825052284N1
Registration date: 2022-09-28, 1401/07/06
Registration timing: prospective

Last update: 2022-09-28, 1401/07/06
Update count: 0
Registration date
2022-09-28, 1401/07/06
Registrant information
Name
salimeh janghorban
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 7343 0000
Email address
sali.cardiology@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-10-23, 1401/08/01
Expected recruitment end date
2023-01-21, 1401/11/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparisson of the Efficacy of Ringer's Lactate Serum as a Base Solution in Modified Del Nido Cardioplegia with Standard Del Nido Cardioplegia on Myocardial Damage Markers and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft
Public title
Comparisson of the Efficacy of Ringer's Lactate Serum as a Base Solution in Modified Del Nido Cardioplegia with Standard Del Nido Cardioplegia on the Outcomes in Patients Undergoing Coronary Artery Bypass Graft
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Candidate patients for coronary artery bypass graft Candidate patients for 3 to 4 vascular grafts Age between 18 and 75 years Written informed consent to participate in the study An ejection fraction higher than 35% before surgery Lack of multi-organ failure before surgery
Exclusion criteria:
Re-operation Proven infection or inflammation within the last month
Age
From 18 years old to 75 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Participant
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
The randomization method is a simple randomization that is done in the form of individual random units. The tool used to do this is a random numbers table. The method of constructing a random sequence is that first the researcher selects one of the numbers with his eyes closed and then moves in the right direction. Odd numbers are considered for intervention and even numbers are for control. Random concealment is also performed using sequentially numbered sealed opaque envelopes (SNOSE).
Blinding (investigator's opinion)
Single blinded
Blinding description
In this single-blinded study, patients who are candidates for coronary artery bypass grafting are blind to the group assignment. Others, including treating physician, methodologist, statistics specialist, nurses, authors of manuscript, and study designers, will be aware of the classification of patients into the two groups.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research Ethics Committees of School of Medicine, Shahid Beheshti University of Medical Sciences
Street address
School of medicine of Shahid Beheshti University of medical sciences, Koodakyar Ave., Daneshjoo Blvd,. Yaman St,. Chamran highway.
City
Tehran
Province
Tehran
Postal code
1985717443
Approval date
2022-04-12, 1401/01/23
Ethics committee reference number
IR.SBMU.MSP.REC.1401.023

Health conditions studied

1

Description of health condition studied
Coronary artery bypass graft
ICD-10 code
T82.2
ICD-10 code description
Mechanical complication of coronary artery bypass graft and biological heart valve graft

Primary outcomes

1

Description
Ejection fraction
Timepoint
Before surgery, after surgery, and 24 hours after admission to the intensive care unit
Method of measurement
Echocardiography

2

Description
Duration of mechanical ventilation
Timepoint
Daily after surgery
Method of measurement
Medical record of the patients

3

Description
Arrhythmia incidence
Timepoint
Daily after surgery
Method of measurement
Electrocardiogram device and cardiologist's interpretation

4

Description
Inotrope administration
Timepoint
Daily after surgery
Method of measurement
Medical record of the patients

Secondary outcomes

1

Description
Troponin level
Timepoint
Before surgery, after surgery, and 24 hours after admission to the intensive care unit
Method of measurement
Laboratory report

2

Description
Lactate dehydrogenase level
Timepoint
Before surgery, after surgery, and 24 hours after admission to the intensive care unit
Method of measurement
Laboratory report

Intervention groups

1

Description
Intervention group A: In this study, Ringer's lactate solution is used to cardioplegia in group A (modified Del Nino).
Category
Treatment - Drugs

2

Description
Intervention group B: In this study, plasmalit A solution is used to cardioplegia in group B (Del Nino standard).
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Imam Hossein Hospital
Full name of responsible person
Salimeh Janghorban
Street address
Imam Hossein Hospital, Shahid Madani St., Imam Ali Highway, Tehran
City
Tehran
Province
Tehran
Postal code
1617763141
Phone
+98 21 7343 3000
Email
info@ehmc.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Dr. Afshin Zarghi
Street address
Shahid Beheshti University of Medical Sciences, No. 2, Arabi St., Yemen St., Chamran Highway, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1983969411
Phone
+98 21 2243 9780
Email
Mpajouhesh@sbmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Salimeh Janghorban
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Cardiology
Street address
No. 2, Derakhti Ave., Hosseininejad Ave., Salman Farsi Ave., Namjoo St., Tehran
City
Tehran
Province
Tehran
Postal code
1615614361
Phone
+98 21 7757 9045
Email
Sali.cardiology@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Salimeh Janghorban
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Cardiology
Street address
No. 2, Derakhti Ave., Hosseininejad Ave., Salman Farsi Ave., Namjoo St., Tehran
City
Tehran
Province
Tehran
Postal code
1615614361
Phone
+98 21 1157 9045
Email
Sali.cardiology@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Salimeh Janghorban
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Cardiology
Street address
No. 2, Derakhti Ave., Hosseininejad Ave., Salman Farsi Ave., Namjoo St., Tehran
City
Tehran
Province
Tehran
Postal code
1615614361
Phone
+98 21 7757 9045
Email
Sali.cardiology@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...